| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.1 | 0.3 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.3 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.31 | 0.3 |